Profiles of B-cell subsets in immunologically stable renal allograft recipients and end-stage renal disease patients
{{output}}
Background: Post-transplantation pharmacotherapies typically employ combinations of immunosuppressive agents that have been designed for targeted inhibition of T-cells and T-cell subsets. Studies of acute and chronic effects of c... ...
